(Q38252696)

1 September 2017

0 references

1 reference

title

Aspirin use after diagnosis but not prediagnosis improves established colorectal cancer survival: a meta-analysis (English)

1 reference

1 September 2017

1 reference

1 reference

1 reference

1 reference

7

Dajing Xia

1 reference

1 September 2017

5

Jinming Xu

1 reference

1 September 2017

Peiwei Li

1

1 reference

1 September 2017

Han Wu

2

1 reference

1 September 2017

Honghe Zhang

3

1 reference

1 September 2017

Yu Shi

4

1 reference

1 September 2017

Yao Ye

6

1 reference

1 September 2017

Jun Yang

8

1 reference

1 September 2017

Jianting Cai

9

1 reference

1 September 2017

Yihua Wu

10

1 reference

1 September 2017

language of work or name

English

0 references

publication date

19 September 2014

1 reference

1 September 2017

1 reference

1 September 2017

volume

64

1 reference

1 September 2017

issue

9

1 reference

1 September 2017

page(s)

1419-1425

1 reference

1 September 2017

cites work

Cancer statistics, 2014

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308260

21 January 2018

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308260

Evaluation of PIK3CA mutation as a predictor of benefit from nonsteroidal anti-inflammatory drug therapy in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308260

Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308260

Aspirin and cancer: has aspirin been overlooked as an adjuvant therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308260

Expression of HLA class I antigen, aspirin use, and survival after a diagnosis of colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308260

Use of aspirin post-diagnosis in a cohort of patients with colorectal cancer and its association with all-cause and colorectal cancer specific mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308260

Effect of aspirin and NSAIDs on risk and survival from colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308260

Aspirin use and survival after diagnosis of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308260

The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308260

Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308260

Low-dose aspirin use after diagnosis of colorectal cancer does not increase survival: a case-control analysis of a population-based cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308260

Aspirin and other non-steroidal anti-inflammatory drug use and colorectal cancer survival: a cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308260

Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308260

Use of aspirin postdiagnosis improves survival for colon cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308260

Prediagnostic non-steroidal anti-inflammatory drug use and survival after diagnosis of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308260

Nonsteroidal anti-inflammatory drugs: effects on mortality after colorectal cancer diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308260

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308260

Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308260

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308260

Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308260

The role of aspirin in cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308260

Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308260

Epithelial-to-mesenchymal transition and autophagy induction in breast carcinoma promote escape from T-cell-mediated lysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308260

Aspirin and the risk of colorectal cancer in relation to the expression of COX-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308260

Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308260

Cytoplasmic phospholipase A2 levels correlate with apoptosis in human colon tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308260

Cyclooxygenase-2 expression: a significant prognostic indicator for patients with colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308260

High frequency of mutations of the PIK3CA gene in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308260

PI3-kinase/Wnt association mediates COX-2/PGE(2) pathway to inhibit apoptosis in early stages of colon carcinogenesis: chemoprevention by diclofenac

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308260

Inhibition of NF-kappa B by sodium salicylate and aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308260

Sodium salicylate induces apoptosis via p38 mitogen-activated protein kinase but inhibits tumor necrosis factor-induced c-Jun N-terminal kinase/stress-activated protein kinase activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308260

Pronounced reduction in adenoma recurrence associated with aspirin use and a polymorphism in the ornithine decarboxylase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308260

Suppression of human colorectal mucosal prostaglandins: determining the lowest effective aspirin dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308260

The utility of Aspirin in Dukes C and High Risk Dukes B Colorectal cancer--the ASCOLT study: study protocol for a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308260

10.1136/GUTJNL-2014-308260

21 January 2018

Identifiers

DOI

1 reference

1 September 2017

1 reference